baber/WOPTO huggingface dataset:
Patent CA-2425265-A1 (CA)
Inventor: NEKHAYEV DMITRY
IPC: H04R25/00
Filed: 2001-10-05
Abstract: L'invention concerne des procédés, un appareil et un programme informatique qui fournissent des techniques efficaces pour concevoir et imprimer des coquilles de prothèses auditives avec un degré élevé de garantie de qualité et de fiabilité et par un nombre réduit d'étapes et d'opérations de production manuelles et longues. Ces techniques produisent en outre des coquilles de prothèses auditives ayant des volumes intérieurs proches d'un taux maximal permis de volume intérieur par rapport au volume extérieur. Ces volumes intérieurs élevés facilitent l'introduction de composants électriques de prothèses auditives ayant des degrés de fonctionnalité supérieurs et/ou l'utilisation de coquilles de prothèses auditives plus petites et plus discrètes. Un procédé préféré consiste à générer un modèle numérique étanche de coquille de prothèse auditive en épaississant un modèle numérique tridimensionnel d'une surface de coquille d'une manière qui élimine les auto-intersections et aboutit à un modèle plus épais ayant un volume intérieur représentant un pourcentage élevé d'un volume extérieur du modèle. Cette opération d'épaississement consiste de préférence à épaissir de façon non uniforme le modèle numérique d'une surface de coquille autour d'une trajectoire dirigée qui identifie l'emplacement d'un évent de prothèse auditive subsurface. Cette trajectoire dirigée peut être dessinée sur la surface de coquille par un technicien (p. ex. un orthoprothésiste) ou un opérateur de CAD, par exemple. Les opérations sont ensuite exécutées pour générer un modèle numérique d'un évent de prothèse auditive subsurface dans le modèle plus épais de la surface de coquille, à un emplacement proche de la trajectoire dirigée.
Patent CA-2429703-A1 (CA)
Title: Removal of targeted proteases with proteinaceous wound dressings
Inventor: TYRRELL DAVID JOHN
IPC: A61L15/32
Filed: 2001-12-17
Abstract: A wound dressing and method for treating a wound with a wound dressing are provided. In particular, the wound dressing contains a fibrous component, for example, made from silk fibers or wool fibers for attracting and capturing proteases from a wound site that may interfere with the healing of the wound.
Patent CA-2430527-A1 (CA)
Title: Mass spectrometer
Inventor: BATEMAN ROBERT HAROLD
IPC: G01J3/00
Filed: 2003-05-30
Abstract: A mass spectrometer is disclosed comprising a gas collision cell, reaction cell or collisional cooling cell 1 comprising a plurality of electrodes 2. DC potentials are progressively applied to the cell 1 so that ions are urged along the cell 1.
Patent CA-2431124-A1 (CA)
Inventor: LENNON PAUL PHILIP
IPC: H04M1/247
Filed: 2003-06-05
Abstract: A telephone device includes a housing, a microphone, a loudspeaker and an auxiliary input device coupled to the housing. The auxiliary input device generates output in response to user manipulation. A controller within the housing is coupled to the microphone, loudspeaker and auxiliary input device. The controller is responsive to output of the auxiliary input device to enable a caller to expose and invoke advanced or special features of the telephone device.
Patent CA-2431416-A1 (CA)
Inventor: SINDHUSHAYANA NAGABHUSHANA
IPC: H04B17/00
Filed: 2001-12-13
Abstract: A method and an apparatus for waveform quality measurement are disclosed. An  actual signal, representing a waveform channelized both in time and in code is generated by, e.g., an exemplary HDR communication system. Test equipment generates an ideal waveform corresponding to the actual waveform. The test equipment then generates an estimate of offsets between parameters of the actual waveform and the ideal waveform, and the offsets are used to compensa te the actual waveform. The test equipment then evaluates various waveform quality measurements utilizing the compensated actual waveform quality measurements as well as conceptual and practical examples of processing of t he actual waveform and the corresponding ideal waveform by the test equipment a re disclosed. The disclosed method and apparatus may be extended to any wavefor m channelized both in time and in code regardless of the equipment that generated the waveform.
Patent CA-2431519-A1 (CA)
Title: Topical composition and method for treating urinary stress incontinence
Inventor: WYLLIE MICHAEL G
IPC: A61K31/137
Filed: 2001-12-17
Abstract: There is provided a method and composition for treating urinary stress incontinence based upon the topical administration of an alpha-adrenoceptor agonist, such as phenylephrine. A daily dosage of 20mg to 2000mg is suitable , and the composition may conveniently be applied as a cream or gel to the vaginal or peri-urethral area.
Patent CA-2431935-A1 (CA)
Title: Tissue treatment
Inventor: STARK JACOBUS
IPC: G01N1/40
Filed: 2001-12-19
Abstract: The present invention describes a method of isolating or extracting fluid from a tissue comprising treating the tissue with microwaves and collecting the resulting tissue fluid.
Patent CA-2432304-A1 (CA)
Inventor: CECCHIN EUCLIDE
IPC: A47K13/02
Filed: 2003-06-16
Abstract: A toilet seat assembly 10 includes a toilet seat 12 having a seat skin 14 defining the exterior surfaces thereof and a seat core 16 disposed within and surrounded by the seat skin 14 and a cover 18 having a cover skin 20 defining the exterior surfaces thereof and a cover core 22 disposed within and surrounded by the cover skin 20. The assembly is characterized by the cores 16, 22 each comprising a waste material. The waste material may be a single polymer wasted in the process of making other products. Alternatively or in combination therewith, combining a plurality of different materials (including different polymers) from different sources may be employed to formulate the waste material.
Patent CA-2432442-A1 (CA)
Title: Hydrophilic polymer concentrates
Inventor: DOBSON JAMES W JR
IPC: C09K23/00
Filed: 2003-06-16
Abstract: Disclosed is a hydrophilic, water soluble polymer concentrate for addition to aqueous liquids to enhance the properties thereof, particularly to increase the viscosity or decrease the fluid loss of well drilling and servicing fluids, the concentrate comprising a hydrophobic, water insoluble liquid, an organophilic clay suspension agent, the water soluble polymer, and a stabilizing agent comprising one or more acids in an amount from about 0.001% to about 1.5%, one or more anionic surfactants in an amount from about 0.001 % to about 1.0%, one or more nonionic surfactants in an amount from 0.001% to about 0.625% and, from about 0% to about 0.75% of one or more water soluble organic liquids, wherein the total concentration of the stabilizing agent is from about 0.1% to about 2.5%, these percentages being based on the weight of the concentrate. Preferably the stabilizing agent is a microemulsion comprising the acid(s), the anionic surfactant(s), the nonionic surfactant(s), and the water soluble organic liquid(s), and further comprising from about 0.0005% to about 1.0% of one or more water insoluble solvents, and from about 0.001 % to about 2.0% water.
Patent CA-2432456-A1 (CA)
Title: Remineralising dental adhesive film
Inventor: KROPF CHRISTIAN
IPC: A61K6/838
Filed: 2001-12-11
Abstract: The invention relates to a dental adhesive film for the local treatment of teeth by remineralisation. Said film consists of a support material that adheres to the teeth and is soluble or swellable in water and of active ingredients stored in said material. The film contains as its active ingredient a fine-particle calcium salt that is poorly soluble in water, selected from the group containing phosphates, fluorides, fluorophosphates a nd mixtures thereof, preferably hydroxyl apatite and/or fluoroapatite, with an average particle fineness of between 10 and 300 nm (nanometers). In addition , the support material preferably contains a protein component, preferably in the form of a fine-particle composite material consisting of a calcium salt that is poorly soluble in water and protein components.
Patent CA-2432464-A1 (CA)
Inventor: DOMINGUEZ-MANZANARES ESTEBAN
IPC: A61K31/472
Filed: 2001-12-19
Abstract: L'invention concerne de nouveaux composés correspondant à la formule (I) et à la formule (I(a)), ou bien les sels pharmaceutiquement acceptables de ces composés, ainsi que des procédés de traitement de troubles neurologiques et de maladies neurodégénératives, en particulier la douleur et la migraine, le traitement consistant à administrer un composé correspondant à la formule (I) ou à la formule (I(a)), et des procédés de préparation desdits composés de formule (I) ou de formule (I(a)).
Patent CA-2433060-A1 (CA)
Title: Inflatable controlled kite for electrical generation
Inventor: DRESSLER LYLE R
IPC: F03D9/30
Filed: 2003-06-25
Abstract: An inflatable structural member, which utilises flexible cables and attachment points so as to create a rigid sidewall and longitudinal rigidity.  The inflatable structural member is enclosed and attached to an inflatable aerodynamic structure comprising of an aerodynamic skin, the inflatable aerodynamic skin is positioned within a membrane that is physically movable about the inflatable membrane, however is partially attached to the trailing edge of the aerodynamic inflatable skin in a manner as to deform the airfoil in a manner such as an aileron.  An inflatable balloon kite of varying sizes and designs for different uses from personal floatation device to aerial load bearing crane, with ailerons to generate lift and control and support devices such as an electrical generation wind turbine and a heating unit to allow for lighter than air flight as well as be a tethering point for a separate inflatable or lightweight wind driven turbine.
Patent CA-2433164-A1 (CA)
Inventor: SIMEONOFF GEORGE
IPC: E04B1/21
Filed: 2003-06-27
Abstract: New, practical connection of pre-cast column to pre-cast beam with no field welding and with concealed steel ledge. Steel ledges are installed into the column sockets in the field and the beams are simply straddled over them with very little crane time wasted. Ideal for cantilevers or pre-cast sheer-walls connection.
Patent CA-2441850-A1 (CA)
Inventor: PROST ANNE-LISE
IPC: C07K14/705
Filed: 2003-09-22
Abstract: Hybrid proteins associating a membrane protein with an ion channel which is not naturally coupled to said membrane protein and their use as electrical sensors of said membrane protein (receptor, transporter) activity, for studying said membrane proteins, and for detecting and screening molecules of interest.
Patent CA-2444897-A1 (CA)
Title: Sulfate of cephem compound
Inventor: MYOJYO HIDETOSHI
IPC: C07D519/06
Filed: 2002-04-19
Abstract: A high-quality sulfate of a cephem compound (I) represented by the following formula; a solvate of the sulfate; or crystals of the sulfate or solvate. The sulfate is useful as a medicine, e.g., an injection. (I)
Patent CA-2445933-A1 (CA)
Title: Gelatin substitute
Inventor: JONES ROGER TREVOR
IPC: A61K8/96
Filed: 2002-05-10
Abstract: The use of a protein of vegetable origin suitable in capsule or microcapsule manufacture, which protein (a) has a molecular weight of at least 40kD; and (b) is water soluble, whereby a clear aqueous solution can be formed that can produce a clear film on drying.
Patent CA-2446973-A1 (CA)
Title: Low back reflection fiber optic cable termination and method of making same
Inventor: SANDERSON JAMES M
IPC: G02B6/255
Filed: 2003-10-27
Abstract: A method of making a fiber optic cable termination comprises the steps of clamping an optical fiber between two spaced-apart clamps; heating the optical fiber, moving at least one of the clamps toward the other clamp to bend a first portion of the optical fiber into an S-shaped bend, wherein the S-shaped bend includes two or more bends, each having a radius of curvature of less than the diameter of the optical fiber. The step of heating the optical fiber can include the step of applying heat to the optical fiber before, during and after the step of moving at least one of the clamps toward the other clamp to bend the optical fiber or the clamps can be separated to form tapered end on tho optical fiber. A fiber optic cable termination comprising are optical rbcr formed into a S-shined bend, and/or a tapered portion is also disclosed.
Patent CA-2447098-A1 (CA)
Inventor: BEDARD PIERRE
IPC: D21C9/16
Filed: 2003-10-28
Abstract: A method for estimating an optimal dosage of bleaching agent to be mixed with wood chips to be fed to a process for producing pulp characterized by a required brightness value. According to a set of wood chip properties characterizing the wood chips as estimated by a measurement system, corresponding wood chip properties data are fed at the inputs of a neural network 12, as well as an initial dosage value of the bleaching agent. The neural network generates a predicted brightness value for pulp to produce from the inspected wood chips. Te brightness predicted value is compared with the required brightness value to generate error data, which is used to optimize the bleaching agent dosage value by minimizing the error data. Prediction, comparison and optimization steps are repeated with the optimized bleaching agent dosage value until the brightness predicted value substantially reaches the required brightness value, to estimate the optimal bleaching agent dosage.
Patent CA-2450759-A1 (CA)
Title: Method and apparatus for a computer-implemented system for the maintainence of a business relationship between a seller and a buyer
Inventor: HEATON JOHN
IPC: G06Q30/02
Filed: 2002-06-05
Abstract: Disclosed is a computer-implemented method for maintaining a business relationship between a seller (i.e., a first entity) and a buyer (i.e. a second entity). The disparate buyer data on a first entity network: b) establishing a buyer access level (102) function on a first entity network, wherein the buyer level function allows the first entity to provide a buyer with access to a set of buyer data and a set of buyer functions for structuring the set of buyer data; c) establishing a gatekeeper level function (104) that provides access at a gatekeeper buyer contact point on a buyer network to the set of buyer data from the database and the set of buyer functions; and d) establishing a buyer subordinate level (106) user function at a buyer subordinate level user contact point that provides a buyer subordinate level user with access to selected buyer data from the set of buyer data and selected functions from the selected buyer functions at the buyer subordinate level user contact point. Also disclosed is an apparatus that is capable of performing this method.
Patent CA-2451607-A1 (CA)
Title: A thermostable isomerase and use thereof in particular for producing tagatose
Inventor: STOUGAARD PETER
IPC: C12N9/90
Filed: 2002-07-15
Abstract: A novel L-arabinose isomerase active enzyme and its corresponding gene, derived from a thermophilic source are provided. The enzyme is suitable for the production of D-tagatose, a useful low-calories sweetener. The enzyme ma y be obtained from a Thermoanaerobacter species such as Thermoanaerobacter mathranii.
Patent CA-2453073-A1 (CA)
Title: Systemes et procede de sauvegarde d'informations
Inventor: VENKATASUBRAMANIAN KRISHNAN
IPC: G06F17/30
Filed: 2002-07-03
Abstract: L'invention concerne un système permettant d'accorder ou de refuser l'accès à des noeuds sur un réseau, ledit système comprenant un premier noeud disposant d'une liste de noeuds auxquels l'accès au premier noeud peut être accordé ou refusé, et au moins un autre noeud. Les noeuds susmentionnés sont connectés à travers le réseau. Lorsque l'autre noeud tente d'accéder au premier noeud, le premier noeud passe en revue la liste de noeuds, afin de déterminer si l'accès doit être accordé ou refusé à l'autre noeud.
Patent CA-2453383-A1 (CA)
Title: Piperidine derivatives as nmda receptor antagonists
Inventor: HORVATH CSILLA
IPC: A61P27/02
Filed: 2002-07-23
Abstract: The present invention relates to new carboxylic acid amide derivatives of formula (I), wherein U, V, W, X, Y, Z, n and m are as defined as in Claim 1. A further object of the invention are the processes for producing of carboxyli c acid amide compounds of formula (I), and the pharmaceutical manufacture of medicaments containing these compounds, as well as the process of treatments with these compounds, which means administering to a mammal to be treated including human - effective amount/amounts of compounds of formula (I) of th e present invention as such or as medicament. The new carboxylic acid amide derivatives of formula (I) of the present invention are highly effective and selective antagonists of NMDA receptor, and moreover most of the compounds a re selective antagonist of NR2B subtype of NMDA receptor.
Patent CA-2456053-A1 (CA)
Inventor: MAENO YOSHIHIKO
IPC: G01L5/00
Filed: 2002-03-13
Abstract: L'invention concerne un convertisseur de pression insensible à l'erreur de position d'introduction de la pression hydraulique ou à l'interférence de la profondeur d'installation de l'eau et produisant un signal correspondant de façon précise à la pression du sol réelle et permettant d'obtenir une réduction des coûts. Du fait que des filtres (34, 35) sont placés dans un entrefer (10) défini par deux plaques rigides (13, 14) recevant la pression du sol, une pression hydraulique est appliquée mais une pression du sable n'est pas appliquée. Une jauge de poids (41) insensible à la pression hydraulique détecte seulement la pression du sol réelle. Etant donné qu'un câble signal (51) peut passer à travers l'entrefer (10), une pluralité de convertisseurs de pression (1, 2) peut être couplée de manière efficace et étant donné que le câble signal (51, 52) peut être introduit de manière interne, une pression distribuée dans le sens de la profondeur peut également être mesurée de manière précise.
Patent CA-2458339-A1 (CA)
Title: Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid
Inventor: LAUFER STEFAN
IPC: C07D207/20
Filed: 2002-08-21
Abstract: The invention relates to a process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-ylacetic acid, in which 5-benzyl-3,3-dimethyl-3,4-dihydro-2H-pyrrole is reacted with w-bromo-4-chloroacetophenone with formation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine and the acetic acid group is introduced into the 5-position, 5-benzyl-3,3-dimethyl-3,4-dihydro-2H-pyrrole being obtained by hydrogenation of 2,2-dimethyl-4-oxo-5-phenylvaleronitrile or a ketal thereof. The invention also relates to processes for the preparation of intermediates occurring in the above process.
Patent CA-2458558-A1 (CA)
Inventor: SUMMERS BOB
IPC: G06F17/30
Filed: 2002-08-14
Abstract: L'invention concerne un procédé publicitaire, consistant à réaliser une image (15) de haute qualité, à placer une ou plusieurs données publicitaires dans un emplacement prédéfini de l'image (15) de haute qualité et à fixer cette image (15) de haute qualité avec les données publicitaires sur un objet (10) utilitaire. Les données publicitaires sont ainsi placées dans l'image de haute qualité sur un objet, de telle sorte qu'elles paraissent faire partie intégrante de l'objet dans l'image (15) de haute qualité.
Patent CA-2460126-A1 (CA)
Title: Tricyclic indole derivatives as 5-ht ligands
Inventor: FU JIAN-MIN
IPC: A61P25/30
Filed: 2002-09-19
Abstract: The present invention provides compounds of Formula (I) wherein: R1, R2, R3, R4, R5, R6, R7, R8, n, m, and X have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods as well as processes and intermediates useful for preparing compounds of Formula (I). The compounds are 5-HT ligands and are useful for treating diseases wherein modulation of 5-HT activity is desired.
Patent CA-2460778-A1 (CA)
Inventor: HASEGAWA MAMORU
IPC: C12N15/86
Filed: 2002-09-18
Abstract: L'invention concerne une méthode permettant d'examiner un vecteur de virus à ARN à brin négatif présentant une capacité réduite à former des grains ou une cytotoxicité faible ou nulle, et une méthode de construction dudit vecteur. On a découvert que la formation de grains de type virus dans des cellules renfermant un vecteur de virus à ARN à brin négatif peut être régulée par réduction ou suppression de la localisation d'une protéine M exprimée dans lesdites cellules. L'invention concerne enfin une méthode permettant d'examiner un vecteur de virus à ARN à brin négatif présentant une capacité réduite ou nulle à former des grains, une méthode de criblage et une méthode de construction de vecteur de virus à ARN à brin négatif à capacité réduite ou nulle de formation de grains. Le vecteur présentant une capacité réduite ou nulle à former des grains est très utile comme vecteur de thérapie génique, du fait qu'il n'entraîne jamais de lésion cellulaire ou d'induction immunitaire suite à la libération secondaire du virus des cellules dans lesquelles ledit vecteur a été transféré.
Patent CA-2465611-A1 (CA)
Inventor: SCHWARTZ YITZHACK
IPC: A61B19/00
Filed: 2004-04-29
Abstract: A method for performing a procedure at the fossa ovalis in the septal wall of the heart includes the steps of identifying the septal wall of the heart;  identifying the fossa ovalis in the septal wall; tagging a point at the fossa ovalis;  providing a sheath having a body wherein the body has a lumen extending therethrough and an open end at a distal end of the body. The body also has a position sensor at the distal end of the body wherein the position sensor generates signals indicative of a location of the distal end of the body. The sheath is navigated to the fossa ovalis at the tagged point using the position sensor. The fossa ovalis is punctured at the tagged point using a penetrating device.
Patent CA-2469227-A1 (CA)
Inventor: VIKRAMADITHYAN REEBA KANNIMEL
IPC: A61P25/28
Filed: 2002-12-02
Abstract: The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to compounds of the general formula (I) which are predominantly PPAR alpha agonists, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them The present invention also relates to processes for the preparation of novel compounds of formula (I), novel intermediates, processes for their preparation, use of the novel intermediates in the preparation of the above said compounds and their use as antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds.
Patent CA-2469387-A1 (CA)
Title: Liaisons in situ
Inventor: MILBOCKER MICHAEL T
IPC: A61K47/48
Filed: 2002-12-05
Abstract: L'invention concerne une composition adhésive de liaison tissulaire biocompatible renfermant un polyol de fonctionnalité N. Ledit polyol à terminaison comprend au moins un polyisocyanate dans une solution, au moins (N-1) % de la solution contenant un polyisocyanate libre. N peut se situer entre 1,5 et 8. Le polyol peut être un copolymère d'oxyde de polypropylène/polyéthylène ramifié.